Cutaneous precancers in organ transplant recipients: An old enemy in a new surrounding

British Journal of Dermatology, Supplement

Volumn 149, Issue 66, 2003, Pages 40-42

  Ulrich, C ^a   Schmook, T ^a   Nindl, I ^a   Meyer, T ^b   Sterry, W ^a   Stockfleth, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IPM   (Germany)

Author keywords

Actinic keratoses; Imiquimod; Nonmelanoma skin cancer; Organ transplanted recipients

Indexed keywords

FLUOROURACIL; IMIQUIMOD; IMMUNOSUPPRESSIVE AGENT; RETINOID;

ACTINIC KERATOSIS; CHEILITIS; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG SAFETY; ERYTHEMA; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PRECANCER; PRIORITY JOURNAL; SIDE EFFECT; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; ULTRAVIOLET RADIATION; VIRUS ONCOGENE; WART VIRUS;

EID: 0346059374     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0366-077x.2003.05633.x     Document Type: Conference Paper

References (14)

1. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ('actinic kertosis'). J Am Acad Dermatol 2000; 42: S11-S17.
2. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemiologic study on premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33; 222-9.
3. Stockfleth E, Ulrich C, Meyer T et al. Skin diseases following organ transplantation - risk factors and new therapeutic approaches. Transplant Proc 2001; 33: 1848-53.
4. Ferrandiz C, Fuente JM, Ribera M et al. Epidermal displasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33: 590-6.
5. Boyd AS, Stasko T, Cameron GS et al. Histologic features of actinic keratoses in solid organ transplant recipients and healthy controls. J Am Acad Dermatol 2001; 45: 217-21.
6. Fortina AB, Caforio AL, Piaserico S et al. Skin cancer in heart transplant recipient, frequency and risk factor analysis. J Heart Lung Transplant 2000; 19: 249-55.
7. Price ML, Tidman MJ, Fagg NLK et al. Distinctive epidermal atypia in immunosuppression-associated cutaneous malignancy. Histopathology 1988; 13: 89-94.
8. Veness MJ, Quinn DI, Ong CS et al. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience. Cancer 1999; 85: 1758-64.
9. Jackson S, Storey A. E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 2000; 19: 592-8.
10. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86.
11. Cuba M, von Breitenbuch P, Steinbauer M et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002; 8: 128-35.
12. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy. Dermatol Surg 2001; 27: 561-4.
13. Stockfleth E, Meyer T, Benninghoff B et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-502.
14. Berg D, Otley CC. Skin cancer in organ transplant recipients. Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17.